Hyperlipidaemia, diet and simvastatin therapy in steroid-resistant nephrotic syndrome of childhood

Pediatric Nephrology

Volumn 10, Issue 2, 1996, Pages 171-174

  Coleman, Janet E ^a   Watson, Alan R ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Diet; Drug therapy; Hyperlipidaemia; Nephrotic syndrome; Steroid resistant

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; STEROID; TRIACYLGLYCEROL;

ADOLESCENT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY HEIGHT; BODY WEIGHT; CALORIC INTAKE; CHILD; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIET THERAPY; FAT INTAKE; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN INTAKE; REMISSION; TIME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029922939     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00862065     Document Type: Article

References (18)

1. Warwick GL, Packard CJ (1993) Lipoprotein metabolism in the nephrotic syndrome. Nephrol Dial Transplant 8: 385-396
2. Watson AR, Coleman JE (1993) Dietary management in nephrotic syndrome. Arch Dis Child 69: 2: 179-180
3. Consensus Statement on Management and Audit Potential for Steroid Responsive Nephrotic Syndrome (1994) Arch Dis Child 70: 151-157
4. Moorhead JF, Chan MK, El-Nahas M, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet II: 1309-1312
5. Kees-Folts D, Diamond JR (1993) Relationship between hyperlipidaemia, lipid mediators and progressive glomerulosclerosis in the nephrotic syndrome. Am J Nephrol 13: 365-375
6. Ducobu J, Brasseur D, Chaudron J-M, Deslypere J-P, Harvengt C, Muls E, Thomson M (1992) Simvastatin use in children. Lancet 339: 1488
7. Sinzinger H, Schmid P, Pirich CH, Virgolini I, Pesau B, Granegger S, O'Grady J (1992) Treatment of hypercholesterolaemia in children. Lancet 340: 548-549
8. Coleman JE (1994) The kidney. In: Shaw V, Lawson M (eds) Clinical paediatric dietetics. Blackwell, Oxford, pp 130-131
9. Department of Health (1991) Dietary reference values for food energy and nutrients. HMSO, London, UK
10. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, Southgate DAT (1991) McCance and Widdowson's The composition of foods, 5th edn. RSC/MAFF, Cambridge. UK
11. Thomas ME, Harris KPG, Ramaswamy C, Hattersley JM, Wheeler DC, Varghese Z, Williams JD, Walls J, Moorhead JF (1993) Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int 44: 1124-1129
12. Department of Health (1994) Nutritional aspects of cardiovascular disease. HMSO, London, UK
13. Rabelink AJ, Erkelens DW, Hené RJ, Joles JA (1988) Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipaedemia of nephrotic syndrome. Lancet II: 1335
14. Wanner C, Böhler J, Eckardt HG, Weiland H, Schollmeyer P (1994) Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome. Clin Nephrol 41: 138-143
15. Mallick NP, Short CD (1981) The nephrotic syndrome and ischaemic heart disease. Nephron 27: 54-57
16. Wass V, Cameron JS (1981) Cardiovascular disease and the nephrotic syndrome: the other side of the coin. Nephron 27: 58-61
17. MASS investigators (1994) Effect of simvastatin on coronary atheroma: the multicentre Anti-Atheroma Study (MASS). Lancet 344: 633-638
18. Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389